DE69940881D1 - Metabolisch inerte antifolate mit entzündungshemmender und anti-tumor wirkung - Google Patents

Metabolisch inerte antifolate mit entzündungshemmender und anti-tumor wirkung

Info

Publication number
DE69940881D1
DE69940881D1 DE69940881T DE69940881T DE69940881D1 DE 69940881 D1 DE69940881 D1 DE 69940881D1 DE 69940881 T DE69940881 T DE 69940881T DE 69940881 T DE69940881 T DE 69940881T DE 69940881 D1 DE69940881 D1 DE 69940881D1
Authority
DE
Germany
Prior art keywords
inflammatory
tumor effect
metabolic
antifolate
inert antifolate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69940881T
Other languages
English (en)
Inventor
Madhavan G Nair
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69940881D1 publication Critical patent/DE69940881D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69940881T 1998-01-17 1999-01-13 Metabolisch inerte antifolate mit entzündungshemmender und anti-tumor wirkung Expired - Lifetime DE69940881D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/008,613 US5912251A (en) 1998-01-17 1998-01-17 Metabolically inert anti-inflammatory and anti-tumor antifolates
PCT/US1999/000948 WO1999036409A1 (en) 1998-01-17 1999-01-13 Metabolically inert anti-inflammatory and anti-tumor antifolates

Publications (1)

Publication Number Publication Date
DE69940881D1 true DE69940881D1 (de) 2009-06-25

Family

ID=21732611

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69940881T Expired - Lifetime DE69940881D1 (de) 1998-01-17 1999-01-13 Metabolisch inerte antifolate mit entzündungshemmender und anti-tumor wirkung

Country Status (5)

Country Link
US (1) US5912251A (de)
EP (2) EP1062209B1 (de)
JP (1) JP4854850B2 (de)
DE (1) DE69940881D1 (de)
WO (1) WO1999036409A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60211670T2 (de) * 2001-04-04 2006-10-26 Bionumerik Pharmaceuticals, Inc., San Antonio Verfahren zur kupplung von aminosäuren an das gerüst eines folsäureantagonisten
GB0219897D0 (en) * 2002-08-27 2002-10-02 Melacure Therapeutics Ab Pharmaceutically active compounds
US7563590B2 (en) * 2002-08-30 2009-07-21 Cypress Bioscience Inc. Methods of quantifying methotrexate metabolites
US20040092739A1 (en) * 2002-11-13 2004-05-13 Zejun Xiao Process for synthesizing antifolates
US7060825B2 (en) * 2003-07-25 2006-06-13 Bionumerik Pharmaceuticals, Inc. Process for synthesizing 6-quinazolinyl-ethyl-benzoyl and related antifolates
US20050032807A1 (en) * 2003-08-06 2005-02-10 Rosenwald Lindsay A. Methods of treating inflammatory diseases with ammonium salts of ornitihine derivatives
WO2006029385A2 (en) * 2004-09-08 2006-03-16 Chelsea Therapeutics, Inc. Quinazoline derivatives as metabolically inert antifolate compounds.
CN101652366A (zh) * 2007-01-19 2010-02-17 切尔西治疗公司 新型抗叶酸剂
MX2010010998A (es) * 2008-04-07 2011-01-25 Chelsea Therapeutics Inc Composiciones de antifolato.
US20100260825A1 (en) * 2009-04-13 2010-10-14 Nair Madhavan G Antifolates for the treatment of cardiovascular, inflammatory, neoplastic, autoimmune and related diseases in sublingual dosage units, film strips, or skin patches
AU2010270596A1 (en) * 2009-07-08 2012-02-02 Chelsea Therapeutics, Inc. Stable crystalline polymorphs of the dipotassium salt of (S) -2- {4- [2- (2, 4-diamino-quinazolin-6-yl) -ethyl] -benzoylamino} -4-methylene-pentanedioic acid
JP2013510163A (ja) 2009-11-06 2013-03-21 チェルシー・セラピューティクス，インコーポレイテッド 酵素阻害化合物
WO2012064377A1 (en) 2010-03-29 2012-05-18 Chelsea Therapeutics, Inc. Antifolate compositions
WO2012078708A1 (en) 2010-12-07 2012-06-14 Chelsea Therapeutics, Inc. Combination comprising methotrexate and an antifolate compound
US11344628B2 (en) 2016-08-12 2022-05-31 L.E.A.F. Holdings Group Llc Alpha polyglutamated antifolates and uses thereof
JP7491572B2 (ja) 2018-02-07 2024-05-28 エル．イー．エー．エフ． ホールディングス グループ エルエルシー アルファポリグルタミン酸化ペメトレキセドおよびその使用
EP3749316A4 (de) 2018-02-07 2021-10-27 L.E.A.F Holdings Group LLC Alpha-polyglutamatiertes pralatrexat und verwendungen davon
US12076402B2 (en) 2018-02-07 2024-09-03 L.E.A.F. Holdings Group Llc Alpha polyglutamated antifolates and uses thereof
EP3752156A4 (de) 2018-02-14 2021-10-27 L.E.A.F Holdings Group LLC Gamma-polyglutamiertse pralatrexat und verwendungen davon
US11771700B2 (en) 2018-02-14 2023-10-03 L.E.A.F. Holdings Group Llc Gamma polyglutamated lometrexol and uses thereof
EP3755335A4 (de) 2018-02-14 2022-06-22 L.E.A.F Holdings Group LLC Gamma-polyglutamierte tetrahydrofolate und deren verwendungen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
US4818753A (en) * 1987-09-18 1989-04-04 Sri International Synthesis and method of use for 2, 4 diaminoquinazoline
JP2830008B2 (ja) * 1988-04-01 1998-12-02 武田薬品工業株式会社 縮合ピリミジン誘導体
US4996207A (en) * 1990-01-18 1991-02-26 Nair Madhavan G Three new non-polyglutamatable deazaaminopterins
US5073554A (en) * 1990-01-18 1991-12-17 Nair Madhavan G Two non-polyglutamatable antifolates
US5550128A (en) * 1994-09-09 1996-08-27 Nair; Madhavan G. Enantiomers of gamma methylene 10-deaza aminopterin and process for preparing the same
US5593999A (en) * 1995-06-07 1997-01-14 Nair; Madhavan G. Non-classical folate analogue inhibitors of glycinamide ribonucleotide formyltransferase (GARFT)

Also Published As

Publication number Publication date
EP1535911A1 (de) 2005-06-01
JP4854850B2 (ja) 2012-01-18
US5912251A (en) 1999-06-15
EP1062209A1 (de) 2000-12-27
JP2002509139A (ja) 2002-03-26
EP1062209B1 (de) 2009-05-13
WO1999036409A1 (en) 1999-07-22
EP1062209A4 (de) 2002-02-27

Similar Documents

Publication Publication Date Title
DE69940881D1 (de) Metabolisch inerte antifolate mit entzündungshemmender und anti-tumor wirkung
DE69703207D1 (de) Verbindungen mit entzündungshemmender und immunsuppressiver wirkung
ATE302200T1 (de) Barbitursaure derivaten mit antimetastatischer und antitumorischer wirkung
DE69943335D1 (de) Ionenleitende matrizen und deren verwendung
ATE278686T1 (de) Phthalazines mit angiogenesis-hemmender wirkung
ATE288903T1 (de) Heterocyclische azahexan-derivate mit antiviraler wirkung
DE59914949D1 (de) Strahlungaussendendes und/oder -empfangendes bauelement
LV12579B (lv) Veja energetiska iekarta un energijas parveidosanas panemiens
DE69942359D1 (de) Beleuchtungsschirm in tandemanordnung
DE60041124D1 (de) Ruktur mit kontrollierten eigenspannungen
MA26612A1 (fr) Pyrazolopyrimidines et pyrazolotriazines
DE69824724D1 (de) Entzündungshemmende piperazinyl-benzyl-tetrazolderivate und deren zwischenprodukte
DE69829323D1 (de) Absorbierende Produkte mit Anpassungshilfen
DE69915066D1 (de) Biozide zusammensetzung und deren verwendung
ID27776A (id) Bahan dengan efek antidepresan
DE69931673D1 (de) Verstärker mit variabler Verstärkung
DE69405421D1 (de) Verstellbares Kettenrad und Komponenten davon
DE60010280D1 (de) Substituierte pyridazinen und kondensierte pyridazinen mit angiogenesis-inhibierender wirkung
DE59804589D1 (de) Halbleiter strombegrenzer und deren verwendung
DE69916694D1 (de) 2-Hydroxy-5-methyl-hexan-3-on und 3-hydroxy-5-methyl-hexan-2-on
ITTO20010110A0 (it) Nuovi derivati benzamidinici dotati di attivita' anti-infiammatoria ed immunosoppressiva.
FR2760102B1 (fr) Autodirecteur orientable
DE60124591D1 (de) Agastache rugosa extrakt mit entzündungshemmender wirkung und antiatherogener wirkung
DE69626753D1 (de) Mikrostreifenleiterantenne mit kleinen Abmessungen und veränderbarer Leistung
DE59508820D1 (de) Elektrolumineszierende Anordnungen und deren Verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition